889939-56-4 Usage
General Description
6-BOC-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID is a complex chemical compound that belongs to the class of organic compounds known as thienopyridines. It is a carboxylic acid derivative with a tetrahydrothieno[2,3-c]pyridine core structure. 6-BOC-4,5,6,7-TETRAHYDRO-THIENO[2,3-C]PYRIDINE-3-CARBOXYLIC ACID is often used as a building block in organic synthesis and medicinal chemistry, where it serves as a precursor for the synthesis of various pharmaceutical compounds and agrochemicals. It can be used as a protecting group for amino acids and a key intermediate in the synthesis of bioactive molecules. Its unique structure and reactivity make it a valuable tool in the development of novel drugs and other biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 889939-56-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,9,9,3 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 889939-56:
(8*8)+(7*8)+(6*9)+(5*9)+(4*3)+(3*9)+(2*5)+(1*6)=274
274 % 10 = 4
So 889939-56-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H17NO4S/c1-13(2,3)18-12(17)14-5-4-8-9(11(15)16)7-19-10(8)6-14/h7H,4-6H2,1-3H3,(H,15,16)
889939-56-4Relevant articles and documents
PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF
-
Paragraph 00288; 00573-00574; 00579-00580; 00605-00606, (2021/09/26)
The present disclosure provides compounds of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled compounds, and prodrugs thereof. The provided compounds may be tumor necrosis factor ("TNF") receptor associated protein 1 ("TRAP1") modulators (e.g., TRAP1 activators). The provided compounds may also rescue the activity in PTEN-induced kinase 1 ("PINK1") loss of function contexts. The provided compounds may also improve mitochondrial health, function, quality, quantity, and/or activity, and/or reduce the production of reactive oxygen species. The provided compounds may also refold or solubilize aggregated or misfolded proteins such as a-synuclein. The present disclosure also provides pharmaceutical compositions comprising the provided compounds; kits comprising the provided compounds or pharmaceutical compositions; and methods of using the provided compounds and pharmaceutical compositions (e.g., for treating a disease in a subject in need thereof).
